Coridea
- Company typePrivate
- Founded2003
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Coridea firmographics
Firmographics- Name
- Coridea
- Legal name
- Coridea
- Website
- https://coridea.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where Coridea is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Coridea business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Investment Returns from Portfolio Companies: Coridea generates returns through founding, funding, and developing medical device companies. Returns are realized when portfolio companies achieve exits through M&A, IPO, or continued revenue growth.
Go-to-market motion1 record
Coridea product offering
Product offeringCore offering
Coridea is a medical device venture studio that identifies clinical opportunities and founds, funds, and develops medical device companies targeting cardiovascular, respiratory, and renal patients. The firm provides state-of-the-art laboratories in New York City, combines clinical/scientific/business expertise, and supports portfolio companies from concept through commercialization, having founded 15 companies and returned $1.6B+ to investors.
Product overview
Coridea is a medtech investment and company-building firm that operates as a single unified platform focused on healthcare innovation. The core offering is the Coridea Portfolio, which encompasses multiple portfolio companies (Axon Therapies, Corvent Medical, Respicardio, EP Sciences, Nuwellis, Reprieve Cardiovascular, CibiEM, Ardian, and RenalGuard) developing medical devices and therapies across cardiovascular, respiratory, sleep apnea, electrophysiology, fluid management, and urology domains. Coridea provides state-of-the-art labs and offices in New York City to support these portfolio companies, having founded 15 companies and returned over $1.6B to investors while securing $12M+ in NIH Grants.
Differentiator
Problem solved
Functional benefit
Products and services
- Coridea Medical Device Venture Studio End-to-end medtech company-building service: identifying clinical opportunities, founding companies, funding R&D, providing state-of-the-art New York City lab and office infrastructure, and developing cardiovascular, respiratory, and renal medical devices through to commercialization or exit. Targeted at investors and strategic partners seeking exposure to validated meddevice ventures.
Quantifiable outcome
- $1.6B+ returned to investors across 15 companies founded
- +1 more outcomes
Companies that use Coridea
Customer profileSegments1 record
Ideal customer profiles2 records
Coridea technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Coridea partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights3 records
Coridea competitors and assessment
Company assessmentBroad incumbents
- Versant Ventures: Versant Ventures is a healthcare-focused venture firm that builds and backs medical device and biotech companies (including founding its own portfolio companies) — a broader incumbent with overlapping cardiovascular and device investing activity.
- SV Health Investors: SV Health Investors (formerly SV Life Sciences) is a healthcare-focused venture and growth firm investing across medtech, biotech, and digital health — a broad incumbent with overlapping medical device exposure.
- OrbiMed: OrbiMed is a large healthcare-dedicated investment firm active across medical devices, biotech, and healthcare services — a broad incumbent that competes for the same cardiovascular and renal device deal flow.
- NEA (New Enterprise Associates): NEA is a large multi-stage venture firm with a substantial healthcare practice that invests in medical device companies — a broad incumbent comparable to Coridea on the medical device investment side, though not a venture studio.
- JLABS (Johnson & Johnson Innovation): JLABS is Johnson & Johnson's external medical device and biotech incubator network — a corporate broad incumbent that incubates and accelerates early-stage healthcare companies in a model comparable to Coridea's venture studio.
- Deerfield Management: Deerfield Management is a healthcare-focused investment firm that finances public and private healthcare companies across devices and therapeutics — a broad incumbent with comparable medical device investment activity.
Direct peers
- The Foundry: The Foundry is a pioneering medical device incubator (founded by Hanson Gifford and others) that builds and spins out cardiovascular and other device companies — directly comparable to Coridea's medtech venture studio model and clinical focus.
- ExploraMed: ExploraMed is a medical device incubator founded by Josh Makower (also co-founder of Coridea) that creates and develops novel device companies — a near-clone of Coridea's model with overlapping founder DNA.
- Fogarty Institute for Innovation: Fogarty Institute is a nonprofit medical device incubator located near Stanford that supports physician-driven medtech innovation — a peer operating model targeting the same inventor-founder pipeline Coridea accesses.
- InCube Labs: InCube Labs is a medical device incubator founded by Mir Imran that conceives, develops, and spins out multiple device companies across therapeutic areas — the closest operational analog to Coridea's venture studio approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Coridea social profiles
Digital presenceCoridea financial estimates
Financial estimateRevenue estimate
Valuation estimate
Coridea leadership team
Management profileNumber of profiles
Profiles5 records
Coridea funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Coridea M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Coridea
What does Coridea do?
Coridea is a medical device venture studio that identifies clinical opportunities and founds, funds, and develops medical device companies targeting cardiovascular, respiratory, and renal patients. The firm provides state-of-the-art laboratories in New York City, combines clinical/scientific/business expertise, and supports portfolio companies from concept through commercialization, having founded 15 companies and returned $1.6B+ to investors.
When was Coridea founded?
Coridea was founded in 2003. It employs 1 to 10 people.
Where is Coridea based?
Coridea is headquartered in New York, United States, in the North America region.
How does Coridea make money?
One revenue line is on record: investment Returns from Portfolio Companies.
Who are Coridea's main competitors?
Broad incumbents on record are Versant Ventures, SV Health Investors, OrbiMed, NEA (New Enterprise Associates), JLABS (Johnson & Johnson Innovation) and Deerfield Management. Direct peers are The Foundry, ExploraMed, Fogarty Institute for Innovation and InCube Labs.
Does Coridea have an API?
No public API is recorded for Coridea.